NDC 50268-331 – Flucytosine
Flucytosine 250 mg/1 · Capsule · Oral
Product NDC50268-331
Product details
- Brand name
- Flucytosine
- Generic name
- Flucytosine
- Labeler
- AvPAK
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA204652
- Marketed since
- April 12, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Nucleoside Analog Antifungal
Active ingredients
- Flucytosine 250 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50268-331-12 | 20 BLISTER PACK in 1 BOX (50268-331-12) / 1 CAPSULE in 1 BLISTER PACK (50268-331-11) | Apr 12, 2021 |
Other Flucytosine products
- 60687-610 Flucytosine 500 mg/1 · Capsule · American Health Packaging
- 60687-599 Flucytosine 250 mg/1 · Capsule · American Health Packaging
- 59651-332 Flucytosine 500 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-331 Flucytosine 250 mg/1 · Capsule · Aurobindo Pharma Limited
- 50268-332 Flucytosine 500 mg/1 · Capsule · AvPAK
- 23155-860 Flucytosine 250 mg/1 · Capsule · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 23155-861 Flucytosine 500 mg/1 · Capsule · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 42385-983 Flucytosine 250 mg/1 · Capsule · Laurus Labs Limited
- 42385-984 Flucytosine 500 mg/1 · Capsule · Laurus Labs Limited
- 43386-770 Flucytosine 500 mg/1 · Capsule · Lupin Pharmaceuticals,Inc.
- 43386-771 Flucytosine 250 mg/1 · Capsule · Lupin Pharmaceuticals,Inc.
- 0904-6835 Flucytosine 500 mg/1 · Capsule · Major Pharmaceuticals